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Background: Prunus yedoensis (PY) is a traditional anti-allergy and anti-inflammatory herb medicine used in South
Korea. However, until date, little is known regarding its mechanism of action.
Methods: In order to elucidate the mechanism of anti-inflammatory effect of PY, the constituents of PY were
analysed by high performance liquid chromatography (HPLC), and nitric oxide (NO) and prostaglandin E2 (PGE2)
production were measured enzyme-linked immuno sorbent assay (ELISA). The expression levels of inducible nitric
oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and nuclear factor-κB (NF-κB) were also measured by western
blotting in lipopolysaccharide (LPS)-induced RAW 264.7 macrophage cells treated with PY.
Results: The results indicate that (50, 100 μg/mL) methanol and ethyl acetate fractionation extracts of PY not only
inhibited LPS-mediated NO production and iNOS expression, but also decreased LPS-induced PGE2 production and
COX-2 expression. The anti-inflammatory effects of PY were also due to the attenuation of nuclear translocation of
NF-κB, as evaluated by the use of anti-p50 on nuclear fractions. LPS-induced nuclear translocation of NF-κB
decreased significantly by the methanol extract and ethyl acetate fraction of PY. High performance liquid
chromatography (HPLC) analyses revealed that methanol extract and ethyl acetate fraction have similar patterns of
retention time and peaks.
Conclusion: Our results demonstrate that methanol extracts and the ethyl acetate fraction of PY have anti-inflammatory
properties, thus emphasizing the potential of PY as a natural health product.
Keywords: Prunus yedoensis, Inducible nitric oxide synthase, Cyclooxygenase-2, Nuclear factor-κBBackground
The inflammatory response in an organism protects the
host against tissue injury and microbial invasion. As
such this response is short lived, failing which it results
in the pathogenesis of many immune related diseases
[1]. Chronic (or acute) inflammation constitutes multiple
processes, which are activated by inflammatory or immune
cells. Of these activated cells, macrophages play a
central role in managing many different immune
pathological phenomena such as the over-production of* Correspondence: hychoi@khu.ac.kr
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reproduction in any medium, provided the orpro-inflammatory cytokines and inflammatory mediators
[2]. iNOS and COX-2 responsible for the elevated level of
NO and prostaglandins, respectively, are well known key
pro-inflammatory mediators in many diseases [3,4]. Many
studies have shown that the chronic phase of inflammation
is closely associated with an increase in iNOS and COX-2
activity [5,6].
NO has been demonstrated to be an important regulatory
molecule for diverse physiological functions such as
vasodilation, neural communication, and host defence
[7,8]. NO is a free radical generated through the conversion
of L-arginine to citrulline, catalysed by NO synthase
(NOS). NOS in macrophages and hepatocytes is inducible,
and its activation is Ca2+ independent. iNOS catalyses the
formation and release of a large amount of NO, which
then plays a key role in disease pathophysiology [9,10].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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prostaglandin H2, the precursor of a variety of biologically
active mediators such as PGE2, prostacyclin, and thromb-
oxane A2 [11,12]. Two forms of this enzyme have been
identified: COX-1, a constitutive cyclooxygenase, and
COX-2, which is induced and activated at the site of
the inflammation [13-15]. COX-2 is rapidly induced
in macrophages and endothelial cells by pro-inflammatory
cytokines and maybe responsible for the edema and
vasodilation associated with inflammation. Overproduction
of inflammatory mediators involves many diseases, such
as rheumatoid arthritis, chronic hepatitis, and pulmonary
fibrosis [16-18]. Hence, inhibition of the production of
these inflammatory mediators may prevent or suppress a
variety of inflammatory diseases, including sepsis and
endotoxemia [19].
PY is a traditional anti-allergy and anti-inflammatory
herb medicine used in South Korea. However, little is
known about its mechanism of action and effectiveness
as an anti-inflammatory agent. In the present study, we
investigated if a methanol and ethyl acetate extract of
PY inhibits LPS-induced production of nitric oxide,
prostaglandin E2, and the expression of iNOS and COX-2
proteins through the inhibition of NF-κB in macrophages.
Methods
Plant material
The cortex of Prunus yedoensis (PY) was purchased from
an oriental drug company, Dongwoodang co., LTD
(Yeongchen, Kyeongbuk, Republic of Korea). PY was
collected on June, 2007. This plant material was authen-
ticated by Dr. Ho-Young Choi and voucher specimen
(No. PY 001) was deposited in the laboratory of herbology,
college of Oriental Medicine, Kyung Hee University,
Seoul, Korea. The cortex of PY (3 kg) was extracted
with 100% MeOH three times for 3 h under heating
mantle-reflux. The resultant extract was condensed
with rotary vacuum evaporator (N-N series, EYELA,
Japan) and partitioned with Chloroform, Ethyl acetate and
Water fraction. After each partition, the solutions were
filtered and the solvents were evaporated in the rotary
vacuum evaporator. The extract yielded Chloroform
(3.5 g), Ethyl acetate (40 g) and H20 (36.2 g) soluble
extractions.
Cell culture and sample treatment
The murine macrophage cell line, Raw 264.7, was
obtained from the Korea Research Institute of Bioscience
and Biotechnology, South Korea. The cells were grown
in high glucose DMEM Medium (Hyclone Road Logan,
USA) containing 10% fetal bovine serum and 10 ml/L
anti-biotics. Cells were incubated in humidified 5% CO2
atmosphere at 37°C. Cells were incubated with the tested
samples at increasing concentrations (50 or 100 μg/ml)or positive chemical for 1 h and then induced with LPS
(10 μg/ml) for the indicated time.
MTS-tetrazolium salt assay
The Promega CellTiter 96W AQueous Non-radioactive Cell
Proliferation Assay was used to measure the cytotoxicity
of test gases based on numbers of viable cells in culture
(Promega, 2001). The MTS (3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H- tetra-
zolium) assay is based on the ability of viable cells to
convert soluble tetrazolium salt to a formazan product.
After adding MTS/PMS reagent cell cultures were incu-
bated at 37°C for 1 h, and optical densities were measured
using an ELISA plate reader (VersaMax™, Molecular
Device, USA) at a wavelength of 490 nm.
Determinations of nitrite concentrations
The nitrite level in the culture media was analyzed by
using Nitrate/Nitrite Colorimetric Assay kit (Cayman
Chem. Co.). Assays were performed according to the
manufacturer’s protocol. Nitrate standard provided in
the kit was used to construct the standard curve. Briefly,
100 μl of the medium supernatant was mixed with 100 μl
of Griess reagent, and the absorbance was measured
at 540/550 nm using VersaMax™ micro-plate reader
(Molecular Device, USA).
Determinations of prostaglandin E2 concentrations
The nitrite level in the culture media was analyzed by
using PGE2 assay kit (R&D system, Parameter
™). Assays
were performed according to the manufacturer’s protocol.
PGE2 standard and RD5-39 provided in the kit was used
to construct the standards curve. Briefly, 100 μl of the
medium supernatant was mixed with 50 μl of primary
antibody solution and PGE2 conjugate. After 2 h incubation
in room temperature with shaker, 96 well was washed
400 μl 1X washing buffer. Color reagent 200 μl was
added, the stop solution 50 μl was mixed after 30 min.
The absorbance was measured at 450/570 nm using
VersaMax™ micro-plate reader (Molecular Device, USA).
Extraction of nuclear protein
Nuclear protein extracts were prepared form RAW
264.7 macrophages using nuclear extract kit (abcam.
USA). Nuclear extractions were obtained according to the
manufacturer’s protocol. Briefly, the cells were washed
in 1 ml of ice-cold PBS in the presence of Phosphatase
inhibitors to limit further protein modifications then
centrifuged at 500 rpm for 5 min in pre-cooled at 4°C.
Gently re-suspend cells in 250 μl of ice-cold 1X Hypotonic
Buffer. Transfer to a micro-centrifuge tube then incubate
for 15 min on ice. Add 10 μl Detergent and vortex
10 seconds at highest setting. Centrifuge suspension for
30 seconds at 14,000 rpm in micro-centrifuge pre-cooled
Figure 1 Effect of PY on cell viability in RAW 264.7 cells. The
cells were incubated 24 h and then pretreated with 100 μg/ml
different PY extracts in 1 hour. Cell viability (5 × 105 cells/ml) was
determined by MTS assay in the presence or absence of LPS (10 μg/ml)
for 24 h. Data represent the mean ± SE of at least three independent
experiments (*p < 0.05, **p < 0.01, ***p < 0.001).
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Buffer (10 mM DTT 2.5 μl, Lysis Buffer AM1 22.25 μl,
Protease Inhibitor Cocktail 0.25 μl) then vortex 10 seconds
at highest setting. Incubate suspension for 30 min on
ice on a rocking platform set at 150 rpm. Vortex 30 seconds
then centrifuge for 10 min at 14,000 rpm in a micro-
centrifuge pre-cooled at 4°C. Transfer supernatant (nuclear
fraction) into a pre-chilled micro-centrifuge tube.
Western blot analysis
Cellular proteins were extracted from PY treated RAW
264.7 cells in the presence or absence of LPS (10 μg/ml)
for 18 h. Cells were collected by centrifugation and washed
once with ice-colded phosphate buffered saline (PBS). The
washed cell pellets were collected by centrifugation and
washed once with phosphate-buffered saline (PBS). The
washed cell pellets were re-suspended in PRO-PREP™
protein extraction solution (Intron Biotechnology, Seoul,
Korea) and incubated for 20 min at 4°C. Cell debris was
removed by micro-centrifugation, followed by quick freezing
of the supernatants. The protein concentration was
determined using the Bio-Rad protein assay reagent
according to the manufacturer’s instructions. Cellular
protein from treated and untreated cell extracts was
electro-blotted onto a PVDF membrane following sepa-
ration on a 10–12% SDS–polyacrylamide gel electropho-
resis. The immune blot was incubated for 1 h with
blocking solution (5% skim milk) at room temperature.
After the membrane was lightly washed with TBST, it was
incubated overnight at 4°C with 1st Ab (1:1000 dilution in
TBST) and then washed three times with TBST. Anti-
rabbit IgG, the secondary Ab (1:2000 dilution in the
blocking solution), was added, followed by incubation for
1 h at RT, then blots were again washed three times with
TBST and reacted to BCIP-NBT solution (Nakanai tesque,
Japan). iNOS, COX-2, p50 and b-actin monoclonal
antibodies and the peroxidase-conjugated secondary
antibody were purchased from Santa Cruz Biotechnology,
Inc. (CA, USA). IκB-α antibody was purchased from Cell
Signaling Technology, Inc. (MA, USA).
HPLC analysis
One miligram of dried methanol extract and Ethyl acetate
fraction of PY was dissolved in 2 ml of 50% acetonitrile
(Duksan Chemical, Korea) and ultra-pure distilled water
and filtered through 0.45 μm syringe filter (PVDF,
Advantec., Japan). The HPLC apparatus was a Gilson
System equipped with a 234 Auto-sampler, a UV/VIS-155
detector and a 321 HPLC Pump (Gilson, U.S.A.). Luna
C18 reversed-phase column with 5- μ particles and 4.60 ×
250 mm (Phenomenex, USA) was operated. The chroma-
tographic separation was carried out using gradient
solvents system with acetonitrile (Duksan Chemical,
Korea) and water (with 0.01% formic acid) within 30 min(0 ~ 20 min: acetonitrile 20%→ 40%, 20 ~ 30 min:
acetonitrile 40%). The column eluent was monitored at
UV 245 nm and then all solvents were degassed with a mi-
cro membrane filter (PTFE, Advantec., Japan). The chro-
matography was performed at room temperature with a
flow-rate of 1.0 ml/min, and 10 μl volume was analyzed.
PY was characterized based on the content of prunetin 5-
O- β –glucopyranoside, 4′-hydroxy-tectochrysin-5-O-β-
glucopyranoside and Genistein 7-O- β –glucopyranoside.
Statistical analysis
The results were expressed as mean ± S.E. for the number
of experiments. Statistical significances were compared
between each treated group and analyzed by the Student’s
t-test. Each experiment was repeated at least three times
and yielded comparable results. P-value of < 0.05(*),
p < 0.01(**), p < 0.001(***) was considered statistically
significant.Results
Effect of PY on cell viability in RAW 264.7 cells
The viability of cultured RAW 264.7 cells was examined
by the MTS assay to test whether PY affects RAW 264.7
macrophages. Cell numbers after 24 h of incubation
were not affected by 4 different extracts of PY at 100 μg/ml
in the presence of LPS (10 μg/ml), except for the activity of
the chloroform fraction. Chloroform extracts at 100 μg/ml
concentration were therefore excluded from the whole
experiment (Figure 1).
Effect of PY on NO production
To investigate the effect of PY on NO production,
accumulation of nitrite, a stable oxidized product of NO,
Figure 2 Effect of PY extracts on lipopolysaccharide
(LPS)-induced NO production in RAW 264.7 cells. The cells were
incubated 24 h and then pretreated with 100 μg/ml different PY
extracts in 1 h. NO production was measured by Nitrite Colorimetric
Assay kit as described in the methods in the presence or absence of
LPS (10 μg/ml) for 18 h. Control (Con.) cells were incubated vehicle
alone. Data represent the mean ± SE of at least three independent
experiments (*p < 0.05, **p < 0.01, ***p < 0.001).
Figure 3 Effect of PY extracts on lipopolysaccharide (LPS)-induced iN
and then pretreated with 100 μg/ml different PY extracts (1 h) in the prese
sample was resolved 10% SDS-PAGE, and western blotting performed. Β-ac
experiments is shown (*p < 0.05, **p < 0.01, ***p < 0.001).
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examined in RAW 264.7 cells stimulated by LPS in the
presence or absence of MeOH, EtOAc, or aqueous (water)
extracts of PY for 18 h. Media of LPS (10 μg/ml)-stimulated
cells contained significantly increased nitrite levels, unlike
that in the controls. The amount of nitrite increased from
1.1 ± 0.0 μM to 7.2 ± 0.1 μM. MeOH, EtOAc, or aqueous
extracts of PY at a concentration of 100 μg/ml each
inhibited nitrite accumulation to 47.7%, 20.9%, and 25.9%,
respectively (Figure 2).
Effect of PY on iNOS protein expression
In order to determine the mechanisms by which PY
reduces LPS-induced NO production, iNOS protein
expression was measured in RAW 264.7 cells exposed to
LPS (10 μg/ml) for 18 h. MeOH and Ethyl acetate
extracts of PY inhibited the induction of iNOS by LPS
(10 μg/ml) (Figure 3).
Effect of PY on PGE2 production
To investigate the effect of PY on PGE2 production,
accumulation of PGE2 was measured. PGE2 accumulation
was examined in RAW 264.7 cells stimulated with
LPS for 18 h in the presence or absence of MeOH,OS expression in RAW 264.7 cells. The cells were incubated 24 h
nce or absence of LPS (10 μg/ml) for 18 h. Protein (100 μg) from each
tin was used as a control. Typical result from three independent
Figure 5 Effect of PY extracts on lipopolysaccharide (LPS)-induced COX-2 expression in RAW 264.7 cells. The cells were incubated 24 h
and then pretreated with 100 μg/ml different PY extracts (1 h) in the presence or absence of LPS (10 μg/ml) for 18 h. Protein (100 μg) from each
sample was resolved 10% SDS-PAGE, and western blotting performed. Β-actin was used as a control. Typical result from three independent
experiments is shown (*p < 0.05, **p < 0.01, ***p < 0.001).
Figure 4 Effect of PY extracts on lipopolysaccharide (LPS)-induced PGE2 production in RAW 264.7 cells. The cells were incubated 24 h
and then pretreated with 100 μg/ml different PY extracts in 1 h. NO production was measured by PGE2 assay kit as described in the methods in
the presence or absence of LPS (10 μg/ml) for 18 h. Control (Con.) cells were incubated vehicle alone. Data represent the mean ± SE of at least
three independent experiments (*p < 0.05, **p < 0.01, ***p < 0.001).
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stimulated cells produced significantly higher PGE2
levels (1994.4 ± 81.8 pg/mL in culture media) compared to
controls (47.0 ± 17.2 pg/mL). The inhibition rates of
MeOH, EtOAc extracts were 68.0%, 42.3% in 100 μg/ml,
each sample concentration (Figure 4).
Effect of PY on COX-2 protein expression
In order to determine the mechanisms by which PY re-
duces LPS-induced PGE2 production, the COX-2 protein
expression was measured in RAW 264.7 cells exposed to
LPS (10 μg/ml) for 18 h. MeOH and Ethyl acetate extracts
of PY inhibited the induction of COX-2 protein by LPS
(10 μg/ml) (Figure 5).
Effect of PY on NF-κB translocation
Given that the NF-κB pathway is one of the major
signalling pathways leading to the activation of iNOS
and COX genes, we evaluated the effect of PY on the
nuclear distribution of the p50 NF-κB protein following
PY treatment. LPS markedly induced the translocation
of p50 to the nucleus, and PY pretreatment significantly
suppressed this translocation (Figure 6). We also exam-
ined whether PY inhibited the phosphorylation andFigure 6 Effect of PY extracts on lipopolysaccharide (LPS)-induced NF
and then pretreated with 100 μg/ml different PY extracts (1 h) in the prese
obtained as described in the methods Nuclear protein was resolved 12% S
independent experiments is shown (*p < 0.05, **p < 0.01, ***p < 0.001).subsequent degradation of the protein, inhibitor of (NF)
κB, (IκB-α). PY pretreatment significantly reduced LPS-
induced IκB-α phosphorylation and prevented IκB-α
degradation (Figure 6).Comparing the constituents of methanol and ethyl
acetate extracts by HPLC
In an effort to compare and characterize the main
constituents of the methanol and Ethyl acetate extracts
of PY, they were analysed by HPLC method. A chromato-
gram of the MeOH extract of PY is shown in Figure 7(a)
and that of the ethyl acetate extract of PY is shown
in Figure 7(b). A comparison of the chromatograms
of both the extracts shows that they have similar
elution profiles and retention time for the major
peaks. The PY extracts were characterized based on
the content of prunetin 5-O- β –glucopyranoside, 4′-
hydroxy-tectochrysin-5-O-β-glucopyranoside, and genistein
7-O- β –glucopyranoside. The retention times of prunetin
5-O- β –glucopyranoside, 4′-hydroxy-tectochrysin-5-O-β-
glucopyranoside, and Genistein 7-O- β –glucopyranoside
in PY extracts were 12.69, 11.82, and 9.60 min, respectively
(Figure 7).-κB expression in RAW 264.7 cells. The cells were incubated 24 h
nce or absence of LPS (10 μg/ml) for 18 h. Nuclear protein was
DS-PAGE, and western blotting performed. Typical result from two
Figure 7 HPLC analysis of the PY and its Ethyl acetate extracts. Standard solution of PY was prepared by dissolving in pure methanol
(HPLC grade, 2 g/100 ml). The injection volume was 10 μl and the detection was made at 254 nm. (a) The chromatography of MeOH extract.
(b) The chromatography of Ethyl acetate extract. (c) The chromatography of standard compound. Typical result from three independent
experiments is shown (*p < 0.05, **p < 0.01, ***p < 0.001).
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The present study was undertaken to elucidate the
pharmacological and biological effects of PY on the
production of inflammatory mediators in macrophages.
The results indicate that methanol and ethyl acetate
extracts of PY (50, 100 μg/ml) were effective inhibitors
of LPS-induced NO, and PGE2 production in RAW
264.7 cells. The data demonstrated that these inhibitory
effects were accompanied by a decrease in the expression
levels of iNOS and COX-2 expression in RAW 264.7
macrophages mediated by the methanol and ethyl
acetate extracts of PY (50, 100 μg/ml). This suppression
was in turn related to the decrease of p50NF-κB nuclear
translocation.
Inflammatory mediators such as NO and pro-inflamma-
tory cytokines are involved in host defence mechanisms,
and their overproduction contributes to the pathogenesis
of several diseases including periodontitis, bacterial sepsis,rheumatoid arthritis, chronic inflammation, and hepatitis
[16,20-22]. During infection and inflammation, the in-
creased production of NO has been shown to cause
mutations and DNA damage [23]. Therefore, pharmaco-
logical interference of NO production has been speculated
to be useful in alleviating numerous disease states that are
mediated by increased and/or protracted activation of
macrophages. The data of the present study indicates that
PY reduced NO production in RAW 26.7 cells.
Prostaglandins also play a major role as mediators of
the inflammatory response. Cyclooxygenase (COX) is an
enzyme that converts arachidonic acid to prostaglandins
[24]. Like NOS, 2 isoforms of COX have been found:
COX-1 and COX-2. COX-1 is expressed constitutively in
most tissues and is responsible for the homeostatic pro-
duction of prostaglandins. In contrast, COX-2 is induced
by several stimuli, including growth factors, mitogens,
cytokines, and tumour promoters. It is responsible for
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prostaglandins at the site of inflammation, and its uncon-
trolled activity is thought to play an important role in the
pathogenesis of many chronic inflammatory diseases
[25-27]. Our data suggests that PY treatment suppressed
LPS-induced expression of COX-2, iNOS, and PGE2 in
RAW 264.7 cells.
NF-κB is composed mainly of 2 proteins, p50 and p65
[28]. In stimulated cells, NF-κB is present in the cytoplasm
and is bound to the inhibitory protein I-κB. Exposure of
cells to various NF-κB activators such as LPS or TNF-α,
results in phosphorylation and degradation of the inhibi-
tory protein I-κB, leading to the release of NF-κB
from I-κB and its translocation into the nucleus. This
study demonstrates the inhibition of LPS-induced I-κB
degradation in the cytosol and a suppression of LPS-
induced activation of NF-κB in the nucleus due to the
action of methanol and ethyl acetate extracts of PY.
Genistein (4′, 5, 7-trihydroxyisoflavone) is a naturally
occurring flavone and the major isoflavone in soybean.
Genistein has been reported to have numerous anti-
oxidative and anti-cancer effects and is known to inhibit
tyrosine-specific protein kinases. Recent studies have
demonstrated that genistein suppresses LPS-induced
inflammatory response by inhibiting NF-κB following AMP
kinase activation in RAW 264.7 Macrophages [29-34]. We
found that extracts of PY contained Genistein 7-O- β –
glucopyranoside, prunetin 5-O- β –glucopyranoside and
4′-hydroxy-tectochrysin-5-O-β-glucopyranoside.Conclusion
In conclusion, we have demonstrated that methanol and
ethyl acetate extracts of PY inhibit LPS-induced NO,
PGE2 production, as well as iNOS and COX-2 expression
in macrophages. This anti-inflammatory effect occurred
via the suppression of the p50 NF-κB nuclear transloca-
tion in LPS-induced RAW 264.7 cells and subsequent
downregulation of iNOS and COX-2 expression. These
data therefore indicate the presence of a novel mechanism
of action underlying the apparent anti-inflammatory
efficacy of this traditional herbal medicine.
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